You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 24, 2024

Investigational Drug Information for Delgocitinib

✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for Delgocitinib?

Delgocitinib is an investigational drug.

There have been 14 clinical trials for Delgocitinib. The most recent clinical trial was a Phase 2 trial, which was initiated on May 10th 2021.

The most common disease conditions in clinical trials are Eczema, Dermatitis, Atopic, and Dermatitis. The leading clinical trial sponsors are LEO Pharma and [disabled in preview].

There is one US patent protecting this investigational drug and forty-three international patents.

Recent Clinical Trials for Delgocitinib
Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand EczemaLEO PharmaPhase 1
Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand EczemaLEO PharmaPhase 3
A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in Adults With Frontal Fibrosing AlopeciaLEO PharmaPhase 2

See all Delgocitinib clinical trials

Clinical Trial Summary for Delgocitinib

Top disease conditions for Delgocitinib
Top clinical trial sponsors for Delgocitinib

See all Delgocitinib clinical trials

International Patents for Delgocitinib

Drugname Country Document Number Estimated Expiration Related US Patent
delgocitinib Argentina AR077497 2029-07-31 ⤷  Sign Up
delgocitinib Australia AU2010278066 2029-07-31 ⤷  Sign Up
delgocitinib Brazil BR112012002157 2029-07-31 ⤷  Sign Up
delgocitinib Canada CA2767899 2029-07-31 ⤷  Sign Up
delgocitinib Chile CL2012000220 2029-07-31 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.